Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older at the time of your stroke.
- You have been confirmed to have had an ischemic stroke (a stroke caused by a blood clot blocking blood flow to the brain), based on the World Health Organization's definition.
- You have had at least one brain scan (either a CT scan or an MRI) that shows one or more areas of the brain affected by the stroke, matching your symptoms.
- You were taking a blood-thinning medication by mouth at the time of your stroke — either a newer type (called a direct oral anticoagulant, or DOAC) taken within the 48 hours before your stroke began, or an older type (called a vitamin K antagonist) with a blood test result showing it was active in your system.
- You have previously been diagnosed with atrial fibrillation (an irregular heartbeat) or another heart rhythm problem that can cause clots to travel to the brain.
Who may not be able to join:
- Your symptoms do not clearly point to an acute (sudden) stroke — for example, if your symptoms were fainting, shaking or jerking movements, dizziness on its own, confusion or memory loss on its own, or a neurological problem that developed slowly over time.
- You were receiving blood-thinning medication through an injection or IV drip (into a vein or under the skin) at the time of your stroke, including heparin injections used as a temporary bridge while starting a vitamin K antagonist.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 0862433561
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
ASPERA-R Primary Outcome Measure: Baseline demographic characteristics; ASPERA-R Primary Outcome Measure: Baseline clinical characteristics; ASPERA-R Primary Outcome Measure: Baseline Neuroimaging characteristics; ASPERA-P Primary Outcome Measure: New ischemic stroke or transient ischemic attack
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.